Last edition
News about Regulation
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.
Regulation | 08/01/2024 | By Manvi | 1298
Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.
Regulation | 30/08/2023 | By Manvi | 990
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.
Regulation | 28/08/2023 | By Manvi | 706
Gland Pharma Receives EIR From USFDA For Dundigal Facility
Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.
Regulation | 25/08/2023 | By Manvi | 882
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Regulation | 25/08/2023 | By Manvi | 1664
Glenmark Pharma settles drug pricing case with US Department of Justice
Glenmark Pharma settles drug pricing case with US Department of Justice
Regulation | 24/08/2023 | By Sudeep Soparkar | 772
Regulation | 22/08/2023 | By Sudeep Soparkar | 763
Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout
Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout
Regulation | 03/08/2023 | By Sudeep Soparkar | 1101
Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.
Regulation | 28/07/2023 | By Manvi | 955
Income Tax Survey at Ipca Laboratories Ltd's plants
The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.
Regulation | 06/06/2023 | By Sudeep Soparkar | 641
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy